[HTML][HTML] Difference between left-sided and right-sided colorectal cancer: a focused review of literature

B Baran, NM Ozupek, NY Tetik, E Acar… - Gastroenterology …, 2018 - ncbi.nlm.nih.gov
Colorectal cancer is the third most common cancer worldwide with a high mortality rate at
the advanced stages. However, colorectal cancer is not a single type of tumor; its …

Mechanisms of PTEN loss in cancer: It's all about diversity

V Álvarez-Garcia, Y Tawil, HM Wise… - Seminars in cancer biology, 2019 - Elsevier
PTEN is a phosphatase which metabolises PIP 3, the lipid product of PI 3-Kinase, directly
opposing the activation of the oncogenic PI3K/AKT/mTOR signalling network. Accordingly …

[HTML][HTML] Clinical-grade detection of microsatellite instability in colorectal tumors by deep learning

A Echle, HI Grabsch, P Quirke, PA van den Brandt… - Gastroenterology, 2020 - Elsevier
Background & Aims Microsatellite instability (MSI) and mismatch-repair deficiency (dMMR)
in colorectal tumors are used to select treatment for patients. Deep learning can detect MSI …

Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells

U Testa, E Pelosi, G Castelli - Medical Sciences, 2018 - mdpi.com
Colon cancer is the third most common cancer worldwide. Most colorectal cancer
occurrences are sporadic, not related to genetic predisposition or family history; however, 20 …

Sexual dimorphism in colon cancer

M Abancens, V Bustos, H Harvey, J McBryan… - Frontiers in …, 2020 - frontiersin.org
A higher incidence of colorectal cancer (CRC) is found in males compared to females.
Young women (18–44 years) with CRC have a better survival outcome compared to men of …

The two faces of tumor-associated macrophages and their clinical significance in colorectal cancer

ML Pinto, E Rios, C Durães, R Ribeiro… - Frontiers in …, 2019 - frontiersin.org
Macrophages are one of the immune populations frequently found in colorectal tumors and
high macrophage infiltration has been associated with both better and worst prognosis …

Landscape of tumor mutation load, mismatch repair deficiency, and PD-L1 expression in a large patient cohort of gastrointestinal cancers

ME Salem, A Puccini, A Grothey, D Raghavan… - Molecular Cancer …, 2018 - AACR
The efficacy of immunotherapy varies widely among different gastrointestinal cancers.
Response to immune checkpoint inhibitors is shown to correlate with tumor mutation load …

Diagnosis and treatment of ERBB2-positive metastatic colorectal cancer: a review

JH Strickler, T Yoshino, RP Graham, S Siena… - JAMA …, 2022 - jamanetwork.com
Importance Amplification ofERBB2 (formerly referred to asHER2) is present in nearly 3% of
patients with metastatic colorectal cancer overall and 5% of patients …

Immune escape and resistance to immunotherapy in mismatch repair deficient tumors

G Mestrallet, M Brown, CC Bozkus… - Frontiers in …, 2023 - frontiersin.org
Up to 30% of colorectal, endometrial and gastric cancers have a deficiency in mismatch
repair (MMR) protein expression due to either germline or epigenetic inactivation. Patients …

Recent trends in the age at diagnosis of colorectal cancer in the US National Cancer Data Base, 2004‐2015

J Virostko, A Capasso, TE Yankeelov, B Goodgame - Cancer, 2019 - Wiley Online Library
Background The incidence of colorectal cancer (CRC) in adults younger than 50 years has
increased in the United States over the past decades according to Surveillance …